← TrialMatch
HomeTrials

To Test an e-Health Educational Intervention Patients With an ICD

Role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study wil

Condition(s)Implantable Cardioverter Defibrillator (ICD)
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryRole of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study will build on previous research by designing, in collaboration with patients, family members and professionals, an online resource to provide important information that can lower anxiety and concerns, and improve quality of life. The CHOICE-ICD resource will be easy to use, incorporating games and quizzes to encourage engagement, up to date information appropriate to each patient's needs, as well as animation clips, virtual reality, and short patient videos. CHOICE-ICD will be m
Who can participateInclusion Criteria: * Patients with heart failure awaiting or with an ICD (no time restriction on implantation) * No cognitive impairment Caregivers: * Have contact with the patient at least 5 times per week. * Be physically and mentally capable of participation (self-assessment) Healthcare professionals: * Daily care of patients with heart failure and an implantable cardioverter defibrillator * Involved in the care of a patient using the Choice-ICD intervention Exclusion Criteria: * Patients, judged by their Cardiologist as physically or mentally unsuitable to complete the study. * Patients or caregivers lacking capacity to give consent. * Patients who have known pregnancy * Caregivers who's patient is unwilling to take participate
Ages18 Years
SexAll
Lead sponsorUniversity of Ulster
LocationsBelfast, County Antrim, United Kingdom; Glasgow, United Kingdom
Start date2025-08-11
NCT IDNCT06667505
Official listinghttps://clinicaltrials.gov/study/NCT06667505

🔍 Search all trials →